Correlation Between Visa and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Visa and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Innate Pharma, you can compare the effects of market volatilities on Visa and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Innate Pharma.
Diversification Opportunities for Visa and Innate Pharma
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Innate is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Visa i.e., Visa and Innate Pharma go up and down completely randomly.
Pair Corralation between Visa and Innate Pharma
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.2 times more return on investment than Innate Pharma. However, Visa Class A is 5.08 times less risky than Innate Pharma. It trades about 0.28 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.13 per unit of risk. If you would invest 27,633 in Visa Class A on September 3, 2024 and sell it today you would earn a total of 3,875 from holding Visa Class A or generate 14.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Innate Pharma
Performance |
| Timeline |
| Visa Class A |
| Innate Pharma |
Visa and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Innate Pharma
The main advantage of trading using opposite Visa and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Visa vs. American Express | Visa vs. Capital One Financial | Visa vs. Upstart Holdings | Visa vs. Ally Financial |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |